Floatz logo

SULANEMADLIN

Lymphoma

Dana-Farber Cancer Instituteprotein_peptidePhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
65/ 100

Competitive context

289 Active assets in the Lymphoma cohort.

Asset / SponsorPhaseRating
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
The Lymphoma Academic Research Organisation
Phase 4BBB
VINBLASTINE
Intensity Therapeutics, Inc.
Phase 4BBB
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
BLEOMYCIN
Shandong Provincial Hospital
Phase 4BB
(+)-VINCRISTINE
Beth Israel Deaconess Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

SULANEMADLIN is also rated in:

medulloblastoma SHH activated and TP53 wild-typeDormant
CC
Indicative ·
46 / 100
View asset →
breast cancerDormant
CC
Indicative ·
45 / 100
View asset →
neoplasmDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →